Related references
Note: Only part of the references are listed.Medical treatment for cholangiocarcinoma
Jorge Adeva et al.
LIVER INTERNATIONAL (2019)
The ALAN score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy
Massimiliano Salati et al.
EUROPEAN JOURNAL OF CANCER (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
Yuko Suzuki et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Noncoding RNA in Cholangiocarcinoma
Massimiliano Salati et al.
SEMINARS IN LIVER DISEASE (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Preoperative prognostic nutritional index predicts survival of patients with intrahepatic cholangiocarcinoma after curative resection
Ozguer Akguel et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
Characterisation of the immune-related transcriptome in resected biliary tract cancers
Michele Ghidini et al.
EUROPEAN JOURNAL OF CANCER (2017)
Serum Extracellular Vesicles Contain Protein Biomarkers for Primary Sclerosing Cholangitis and Cholangiocarcinoma
Ander Arbelaiz et al.
HEPATOLOGY (2017)
miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA)
Bo Zheng et al.
ONCOTARGET (2017)
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles (vol 18, pg 2780, 2017)
Farshad Farshidfar et al.
CELL REPORTS (2017)
Involvement of cytochrome P450 in cisplatin treatment: implications for toxicity
Julia Coelho Franca Quintanilha et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Prognostic factors for progression-free and overall survival in advanced biliary tract cancer
J. Bridgewater et al.
ANNALS OF ONCOLOGY (2016)
International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007
Jessica L. Petrick et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Forty-Year Trends in Cholangiocarcinoma Incidence in the US: Intrahepatic Disease on the Rise
Supriya K. Saha et al.
ONCOLOGIST (2016)
Prognostic nutritional index serves as a predictive marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma
Chenyue Zhang et al.
ONCOTARGETS AND THERAPY (2016)
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy
Luca Faloppi et al.
SCIENTIFIC REPORTS (2016)
Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer
Y. Geng et al.
EJSO (2015)
Preoperative Neutrophil to Lymphocyte Ratio and Prognostic Nutritional Index Predict Overall Survival After Hepatectomy for Hepatocellular Carcinoma
Yukiyasu Okamura et al.
WORLD JOURNAL OF SURGERY (2015)
Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer
M. G. McNamara et al.
EUROPEAN JOURNAL OF CANCER (2014)
The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis
Kaiyu Sun et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
The Prognostic Nutritional Index Predicts Long-term Outcomes of Gastric Cancer Patients Independent of Tumor Stage
Kazuhiro Migita et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma
Tadahiro Nozoe et al.
SURGERY TODAY (2012)
Nutritional predictors of postoperative outcome in pancreatic cancer
M. Kanda et al.
BRITISH JOURNAL OF SURGERY (2011)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Transcriptional repression of hepatic Cytochrome P450 3A4 gene in the presence of cancer
Kellie A. Charles et al.
CLINICAL CANCER RESEARCH (2006)
Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States
Tania M. Welzel et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis
KC Fearon et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2006)
Modulation of cytochrome P450 activity: implications for cancer therapy
CD Scripture et al.
LANCET ONCOLOGY (2005)
Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response
LP Rivory et al.
BRITISH JOURNAL OF CANCER (2002)
Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States
T Patel
HEPATOLOGY (2001)
Share Paper
